Immunocore Holdings plc
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Oxfordshire, United Kingdom
IMCR chart
What traders are saying about $IMCR
Latest postsImmunocore Holdings plc news
- Phase 1 Diabetes Trial Might Change The Case For Investing In Immunocore (IMCR)
Simply Wall Street ·
- IMCR Reiterated by HC Wainwright & Co. -- Price Target Maintained at $100
GuruFocus ·
- Immunocore Holdings Price Target Maintained With a $100.00/Share by HC Wainwright & Co.
Moomoo ·
- HC Wainwright & Co. reiterates Buy rating on Immunocore Holdings, $100 price target
TradingView ·
- Immunocore Holdings plc Estimates – NASDAQ:IMCR
TradingView ·
- Why (IMCR) Price Action Is Critical for Tactical Trading
Stock Traders Daily ·
- Immunocore Doses First Patient in Phase 1 Trial of IMC-S118AI, Its First Tissue-Specific Autoimmune Candidate, for Type 1 Diabetes
BioBuzz ·
- GeneDx Holdings And 2 Other Top Healthcare Stocks
Yahoo Finance ·
- Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes
Yahoo Finance ·
- Top 3 Healthcare Stocks To Watch In October 2026
Yahoo Finance ·
- Immunocore Hits Enrollment Target in Kimmtrak Label Expansion Study
Yahoo Finance ·
- Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma
Yahoo Finance ·
Immunocore Holdings plc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $400.0M | $310.2M | $249.4M | $174.4M |
| Net income | -$35.5M | -$51.1M | -$55.3M | -$52.5M |
| Diluted EPS | $-0.71 | $-1.02 | $-1.13 | $-1.15 |
| Total assets (year end) | $1.07B | $1.01B | $597.0M | $526.8M |
| Cash and equivalents (year end) | $467.7M | $455.7M | $442.6M | $402.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Immunocore Holdings plc
- Ticker
- IMCR (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Oxfordshire, United Kingdom
- Incorporated in
- United Kingdom
- Fiscal year end
- December 31
- SEC CIK
- 1671927
- Former names
- Immunocore Ltd
Frequently asked questions
What exchange is Immunocore Holdings plc listed on?
Immunocore Holdings plc trades on the Nasdaq under the ticker symbol IMCR.
What industry is Immunocore Holdings plc in?
Immunocore Holdings plc is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Immunocore Holdings plc headquartered?
Immunocore Holdings plc's business address on file with the SEC is in Oxfordshire, United Kingdom.
When does Immunocore Holdings plc's fiscal year end?
Immunocore Holdings plc's fiscal year ends on December 31.
How much revenue did Immunocore Holdings plc report?
Immunocore Holdings plc reported $400.0M in revenue for calendar year 2025, according to its SEC filings.